National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 5) (PB 38 of 2019) (Cth)

PB 38 of 2019

National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 5)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated    24 May    2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 5).

(2)This Instrument may also be cited as PB 38 of 2019.

1. Commencement

This Instrument commences on 1 June 2019.

1. Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

1. Schedule 1, entry for Insulin aspart

insert as first entry:

Injection (human analogue) (fast acting) 100 units per mL, 10 mL vial 20 5 2

1. Schedule 1, after entry for Insulin aspart in the form Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

insert:

Injections (human analogue) (fast acting), pre-filled pen, 100 units per mL, 3 mL, 5 20 5 1